United Therapeutics buy UBS Group AG
Start price
06.11.25
/
50%
€393.20
Target price
06.11.26
€521.34
Performance (%)
8.57%
Price
26.02.26
€426.90
Summary
This prediction is currently active. With a performance of 8.57%, the BUY prediction by UBS_Group_AG for United Therapeutics is trending in the right direction. This prediction currently runs until 06.11.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| United Therapeutics | 4.479% | 4.479% |
| iShares Core DAX® | 1.232% | 1.501% |
| iShares Nasdaq 100 | 0.695% | -1.949% |
| iShares Nikkei 225® | 2.085% | 11.061% |
| iShares S&P 500 | 0.419% | 0.215% |
Comments by UBS_Group_AG for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics (NASDAQ:UTHR) had its price target raised by analysts at UBS Group AG from $580.00 to $600.00. They now have a "buy" rating on the stock.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by UBS_Group_AG for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€426.10
06.01.26
06.01.26
€550.12
06.01.27
06.01.27
5.80%
26.02.26
26.02.26
United Therapeutics
Start price
Target price
Perf. (%)
€360.40
29.09.25
29.09.25
€494.80
29.09.26
29.09.26
18.45%
26.02.26
26.02.26
United Therapeutics
Start price
Target price
Perf. (%)
€337.60
04.09.25
04.09.25
€480.20
04.09.26
04.09.26
26.45%
26.02.26
26.02.26
United Therapeutics
Start price
Target price
Perf. (%)
€258.80
13.08.25
13.08.25
€355.41
13.08.26
13.08.26
64.95%
26.02.26
26.02.26
United Therapeutics
Start price
Target price
Perf. (%)
€244.10
30.06.25
30.06.25
€328.48
30.06.26
30.06.26
74.89%
26.02.26
26.02.26
United Therapeutics
Start price
Target price
Perf. (%)
€355.30
08.01.25
08.01.25
€460.94
08.01.26
08.01.26
17.73%
09.01.26
09.01.26
United Therapeutics
Start price
Target price
Perf. (%)
€292.80
08.07.24
08.07.24
€341.51
08.07.25
08.07.25
-14.82%
09.07.25
09.07.25